As you may have heard, IMS Health and Quintiles are now IQVIA™, The Human Data Science Company™. We are excited to share our vision at the 11th edition of Clinical Trials on Alzheimer's Disease from October 24-27, 2018 in Barcelona, Spain.
Start a conversation with our experts, and see how our unique combination of data, insights, technology and domain expertise can help you chart a more predictable path forward in Alzheimer's.
CTAD 2018 will highlight the latest on trying to get Alzheimer's trials off the ground. Overall, the aim of the conference is to overcome the hurdles and speed the development of effective treatments.
Kenneth Stanley, Carolina Rubel, Lynne Hughes - IQVIA Project Leadership
Applying patient-centered insights to optimize protocol design and increase biomarker collection acceptability in AD trials